Is a complete LON/0A8E research report available?

No complete published report is available for lon/0A8E (LON/0A8E) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0A8E (LON/0A8E)

London Stock Exchange: LON/0A8E · USD

$7.75

-0.28 (-3.5%)· Recorded snapshot

Market cap	1B
Revenue (ttm)	252.8M
Net income (ttm)	-12.9M
EPS (ttm)	-$0.08
P/E (forward)	68.1x
Volume	2,303
Beta	0.85

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 252.8M
Net income (ttm): -12.9M
EPS (ttm): -$0.08
P/E (forward): 68.1x
Market cap: 1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All LON/0A8E indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	435
Employees Change	17%
Employees Change Percent	4.51
Enterprise value	$1.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US98422E1038
Last refreshed	2026-09-11
Market cap	$1B
Price	$7.75
Price currency	USD
Rev Per Employee	581,152.95x
Sector	Healthcare
Sector PE	21.2
Sector PE Fwd	13.53
Sic	2834
Symbol	lon/0A8E
Website	https://www.xerispharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.25%
EV/EBIT	43x
EV/EBITDA	27.74x
EV/FCF	27.68x
EV/Sales	4.69x
FCF yield	4.04%
Forward P/E	68.15x
P/B ratio	-141.45x
P/S ratio	4.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.91%
EBITDA Margin	14.54%
FCF margin	16.9%
Gross margin	86.58%
Gross Profit	$218.9M
Gross Profit Growth	43.52%
Gross Profit Growth Q	33.45%
Gross Profit Growth3 Y	38.35%
Gross Profit Growth5 Y	67.12%
Net Income	$-12.9M
Net Income Growth Years	4%
Pretax Margin	-5.12%
Profit Margin	-5.12%
Profit Per Employee	$-29,741
Profitable Years	1
ROA	6.13
Roa5y	-10.92
ROCE	16.46
ROIC	8.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1.98%
Cagr3y	53.67%
EPS Growth Years	7
FCF Growth Qo Q	-15.62%
OCF Growth Q	4,440.11%
OCF Growth Qo Q	-16.28%
Revenue Growth	36.33x
Revenue Growth Q	28.74x
Revenue Growth Qo Q	10.79x
Revenue Growth Quarters	27x
Revenue Growth Years	9x
Revenue Growth3 Y	35.75x
Revenue Growth5 Y	58.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.9
Assets	$310.5M
Cash	$91.8M
Current Assets	$203.3M
Current Liabilities	$140.3M
Debt	$218.2M
Debt EBITDA	$5.1
Debt FCF	$5.2
Equity	$-7.3M
Interest Coverage	1.3
Liabilities	$317.8M
Long Term Assets	$107.1M
Long Term Liabilities	$177.5M
Net Cash	$-126.4M
Net Cash By Market Cap	$-12.18
Net Debt EBITDA	$3.44
Net Debt FCF	$3.01
Tangible Book Value	$-86.9M
Tangible Book Value Per Share	$-0.5
WACC	8.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.45
Inventory Turnover	0.61
Net Working Capital	$25.3M
Quick ratio	0.95
Working Capital	$64.2M
Working Capital Turnover	$2.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1.97%
200-day SMA	7.06
3Y total return	263%
50-day SMA	8.4
50-day SMA vs 200-day SMA	50over200
All Time High	10.09
All Time High Change	-23.19%
All Time High Date	2025-11-05
All Time Low	0.97
All Time Low Change	698.89%
All Time Low Date	2023-01-05
ATR	0.3
Beta	0.85
Ch YTD	-3.49
High	7.98
High52	10.09
High52 Date	2025-11-05
High52ch	-23.19%
Low	7.73
Low52	5.26
Low52 Date	2026-03-26
Low52ch	47.34%
Ma50ch	-7.75%
Price vs 200-day SMA	9.8%
RSI	37.23
RSI Monthly	59.76
RSI Weekly	52.64
Sharpe ratio	0.19x
Sharpe Ratio3y	0.84x
Sortino ratio	0.35
Sortino Ratio3y	1.42
Total Return	-10.29%
Tr YTD	-3.49
Tr1m	-1.52%
Tr1w	-11.22%
Tr3m	21.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	176,004,894%
Shares Insiders	3.46%
Shares Institutions	60.84%
Shares Qo Q	-2.71%
Shares Yo Y	10.29%
Short Ratio	4.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$20.8M
Adjusted OCF	21,470,652
Average Volume	1,667.35x
Bv Per Share	-0.04
CAPEX	$-706,971
Ch1m	-1.52
Ch1w	-11.23
Ch1y	1.97
Ch3m	21.28
Ch3y	263
Ch6m	37.44
Change	-3.46%
Change From Open	-1.27
Close	8.03
Days Gap	-2.24
Depreciation Amortization	9,010,459.2
Dollar Volume	17,848.3
Earnings Date	2026-11-06
EBIT	$27.6M
EBITDA	$36.8M
EPS	$-0.08
F Score	6
FCF	$42M
FCF EV Yield	3.61x
Financing CF	5,042,253
Fiscal Year End	December
Founded	2,005
Goodwill	16,916,071.5
Investing CF	-706,971
Is Primary Listing	0
Last Earnings Date	2026-08-06
Last Report Date	2026-06-30
Ma150	6.99
Ma150ch	10.86%
Ma20	8.53
Ma20ch	-9.11%
Net CF	47,000,732
Next Earnings Date	2026-11-06
Open	7.85
P FCF Ratio	24.73
P FCF Ratio SBC	49.98
P OCF Ratio	24.32
P OCF Ratio SBC	48.33
Position In Range	8
Ppne	19,689,658.9
Price Date	2026-09-10
Price EBITDA	$28.23
Relative Volume	1.77x
Revenue	252,801,532x
SBC By Revenue	8.38x
Share Based Comp	21,194,798
Tr6m	37.45%
Volume	2,303
Z Score	0.6

LON/0A8E (LON/0A8E)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0A8E

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0A8E indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0A8E

Frequently asked questions